ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: Tengion

Tengion enrolls patients in Phase 1 trials

Tengion enrolls patients in Phase 1 trials

January 30, 2013 11:55 pm by | 0 Comments

Tengion Inc. said Wednesday it has enrolled seven patients in its neo-urinary conduit Phase 1 trial and expects to meet its goal of 10 patients by March 31.The Winston-Salem regenerative-medicine ... Read more
Can regenerative medicine firm TNGN conjure a Medtronic partnership?

Can regenerative medicine firm TNGN conjure a Medtronic partnership?

May 25, 2012 11:19 am by | 0 Comments

Regenerative medicine company Tengion (NASDAQ:TNGN) has always planned to take its novel tissue generating technology as far as early-stage clinical studies before finding a partner to finance later-stage work.The company’s ... Read more
Regenerative kidney disease treatment from Tengion planned for 2013 IND

Regenerative kidney disease treatment from Tengion planned for 2013 IND

April 18, 2012 7:00 am by | 0 Comments

Regenerative medicine company Tengion (NASDAQ:TNGN) plans to start human studies on its experimental kidney disease treatment in 2013.Tengion said that it expects to file an investigational new drug application, or ... Read more
Regenerative medicine firm Tengion moves HQ to North Carolina

Regenerative medicine firm Tengion moves HQ to North Carolina

January 6, 2012 3:38 pm by | 0 Comments

Regenerative medicine company Tengion (NASDAQ:TNGN) has relocated its headquarters from Pennsylvania to North Carolina, where the company maintains R&D operations.The move to North Carolina comes nearly two months after Tengion ... Read more
Tengion gets new CEO as it pursues strategic partnership talks

Tengion gets new CEO as it pursues strategic partnership talks

December 6, 2011 8:13 am by | 0 Comments

John L. Miclot has been appointed CEO of Tengion (NASDAQ:TNGN), a regenerative medicine business in East Norriton, Pennsylvania, as it pursues strategic partnership discussions.Miclot fills a vacancy left by Steven ... Read more
TNGN restructures to save cash, focus on R&D while it seeks a partner

TNGN restructures to save cash, focus on R&D while it seeks a partner

November 15, 2011 12:41 pm by | 0 Comments

Regenerative medicine company Tengion (NASDAQ:TNGN) is restructuring with moves that reduce headcount, focus operations on its North Carolina R&D arm and conserve enough cash to last another year.Tengion said the ... Read more
Regenerative medicine: Technology whose time has come

Regenerative medicine: Technology whose time has come

October 7, 2011 7:00 am by | 0 Comments

Regenerative medicine is now Tim Bertram‘s work but in previous chapters of his career, he focused on drugs while working for large pharmaceutical companies such as Pfizer (NYSE:PFE), Smithkline Beecham ... Read more
Tengion shuffles management; CEO search under way

Tengion shuffles management; CEO search under way

August 11, 2011 11:20 am by | 0 Comments

Regenerative medicine company Tengion‘s (NASDAQ:TNGN) Chief Scientific Officer Timothy Bertram will handle CEO duties while the company searches for a new top executive.Former CEO Dr. Steven Nichtberger resigned from the ... Read more
Orphan drug status granted to Tengion tissue regeneration technology

Orphan drug status granted to Tengion tissue regeneration technology

June 10, 2011 12:49 pm by | 0 Comments

Regenerative medicine company Tengion (NASDAQ:TNGN) has been granted orphan drug designation on its technology that is initially being developed to help patients with bladder cancer.Tengion’s platform technology for organ regeneration ... Read more
Medtronic invests in regenerative medicine company Tengion

Medtronic invests in regenerative medicine company Tengion

April 15, 2011 12:58 pm by | 0 Comments

Medtronic Inc. (NYSE:MDT) is hot on technology that could coax the body into producing its own replacement kidney.The Fridley, Minn.-based medical device maker revealed its 17 percent stake and a ... Read more